Speaker Profile
Lisa Dimartino

Lisa Dimartino PhD, MPH

Health Care Policy and Research
Dallas, Texas, United States of America

Connect with the speaker?

Lisa D. DiMartino, Ph.D., M.P.H. is an Assistant Professor at the Peter O’Donnell Jr. School of Public Health with a background in implementation science and health services research. Dr. DiMartino has expertise in examining multi-level factors associated with the adoption of evidence-based interventions across a wide variety of healthcare settings. She uses a combination of research methodologies in her work, from mixed methods and qualitative evaluations to analysis of complex datasets using advanced statistical methods. Dr. DiMartino earned her BA in Psychology, MPH in Health Behavior and Health Education, and PhD in Health Policy and Management, all from the University of North Carolina at Chapel Hill.

Dr. DiMartino is interested in cross-departmental collaborative research related to applying implementation science principles, to improve care for patients with cancer and other chronic diseases. She also has a background in palliative oncologic care research. For example, she recently led a pilot project that used natural language processing (NLP) and electronic health record data to identify hospitalized cancer patients in need of palliative care. She aims to further this research by developing, testing, and implementing an NLP-based strategy to improve care delivery for cancer patients. In addition to cancer and palliative care, Dr. DiMartino has been part of the implementation of science studies addressing the needs of people with conditions such as sickle cell disease, HIV, and tobacco dependence.

Dr. DiMartino is currently a Co-Investigator for the Coordinating Center for the NCI Beau Biden Cancer MoonshotTM Initiative Improving Management of Symptoms During and Following Cancer Treatment (IMPACT) consortium. Before joining UT Southwestern, she was an Implementation Scientist at RTI International, where she served as Co-Investigator for the Coordinating Center for the NHLBI-funded Sickle Cell Disease Implementation Consortium, among other projects.